Suppr超能文献

在直接经皮冠状动脉介入治疗和糖蛋白IIb/IIIa抑制剂时代,心肌梗死后左心室血栓形成的发生率。一项前瞻性观察研究。

Incidence of post myocardial infarction left ventricular thrombus formation in the era of primary percutaneous intervention and glycoprotein IIb/IIIa inhibitors. A prospective observational study.

作者信息

Rehan Arshad, Kanwar Manpreet, Rosman Howard, Ahmed Sujood, Ali Arshad, Gardin Julius, Cohen Gerald

机构信息

Department of Cardiology, St John Hospital and Medical Centre, Wayne State University, Detroit, Michigan 48230, USA.

出版信息

Cardiovasc Ultrasound. 2006 Apr 6;4:20. doi: 10.1186/1476-7120-4-20.

Abstract

BACKGROUND

Before the widespread use of primary percutaneous coronary intervention (PCI) and glycoprotein IIb/IIIa inhibitors (GP IIb/IIIa) left ventricular (LV) thrombus formation had been reported to complicate up to 20% of acute myocardial infarctions (AMI). The incidence of LV thrombus formation with these treatment modalities is not well known.

METHODS

92 consecutive patients with ST-elevation AMI treated with PCI and GP IIb/IIIa inhibitors underwent 2-D echocardiograms, with and without echo contrast agent, within 24-72 hours.

RESULTS

Only 4/92 (4.3%) had an LV thrombus, representing a significantly lower incidence than that reported in the pre-PCI era. Use of contrast agents did not improve detection of LV thrombi in our study.

CONCLUSION

The incidence of LV thrombus formation after acute MI, in the current era of rapid reperfusion, is lower than what has been historically reported.

摘要

背景

在原发性经皮冠状动脉介入治疗(PCI)和糖蛋白IIb/IIIa抑制剂(GP IIb/IIIa)广泛应用之前,据报道,左心室(LV)血栓形成会使高达20%的急性心肌梗死(AMI)病情复杂化。目前尚不清楚采用这些治疗方式时LV血栓形成的发生率。

方法

92例接受PCI和GP IIb/IIIa抑制剂治疗的ST段抬高型AMI连续患者在24至72小时内接受了二维超声心动图检查,检查时使用和未使用超声造影剂。

结果

仅4/92(4.3%)患者出现LV血栓,这一发生率显著低于PCI时代之前报道的发生率。在我们的研究中,使用造影剂并未提高LV血栓的检出率。

结论

在当前快速再灌注时代,急性心肌梗死后LV血栓形成的发生率低于历史报道。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8def/1458359/9efff685c5e9/1476-7120-4-20-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验